JAMA Network
About The Study: In this nationwide assessment of the frequency with which climate-related disaster events affected counties with U.S. drug production facilities, researchers determined that nearly two-thirds of all facilities were located in counties that experienced at least one disaster declaration. These disaster events posed risks of disruptions to facilities active in all aspects of the supply chain, from active pharmaceutical ingredient manufacture to packaging, disruptions that could be further magnified by the time needed for Food and Drug Administration reinspection of damaged facilities.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
